Tesamorelin 10 mg – GHRH-Receptor Research | Pituitary and GH–IGF-1 Signalling | Premium Research Compound

$119.95

A premium research compound supplied in a convenient 10 mg vial.

Tesamorelin is a stabilised synthetic analogue of human growth-hormone-releasing hormone. It is investigated in laboratory and clinical research involving GHRH-receptor activity, pituitary signalling, growth-hormone secretion, the GH–IGF-1 axis, lipid metabolism, and body-composition pathways.

What’s Included

  • 1x Tesamorelin 10 mg vial

  • Over 99% Purity

  • Premium-quality research compound

  • Shipped from the Gold Coast, Queensland

  • Australia Post Express Post

Why Choose Tesamorelin 10 mg?

Tesamorelin is a modified 44-amino-acid analogue corresponding to the full sequence of human growth-hormone-releasing hormone.

Researchers investigate Tesamorelin in relation to:

  • GHRH-receptor activation

  • Pituitary somatotroph-cell activity

  • Growth-hormone secretion pathways

  • GH–IGF-1 axis signalling

  • Pulsatile endocrine activity

  • Lipid-metabolism pathways

  • Adipose-tissue signalling

  • Body-composition research

Its stabilised GHRH-based structure makes Tesamorelin an important compound for specialised endocrine, pituitary, metabolic, and receptor-signalling research.

Tesamorelin Research

Tesamorelin is commonly investigated in laboratory and clinical research relating to:

  • Growth-hormone-releasing hormone activity

  • GHRH-receptor binding and activation

  • Pituitary-cell signalling

  • Growth-hormone secretory responses

  • IGF-1-associated pathways

  • Somatotropic-axis activity

  • Visceral-adipose-tissue metabolism

  • Lipolytic signalling

  • Triglyceride-metabolism pathways

  • Glucose-regulation mechanisms

  • Liver-fat research

  • Body-composition changes

Research continues into how Tesamorelin influences pituitary signalling, endogenous growth-hormone release, IGF-1-associated activity, lipid metabolism, and adipose-tissue pathways.

Growth-Hormone-Releasing Hormone Analogue Research

Tesamorelin is a synthetic analogue of human GHRH (1–44) with an N-terminal modification designed to improve resistance to enzymatic degradation.

It is composed of the following 44-amino-acid sequence:

Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Researchers investigate this specialised peptide for its potential to:

  • Bind to growth-hormone-releasing hormone receptors

  • Activate receptor-mediated pituitary signalling

  • Influence endogenous growth-hormone secretion

  • Affect GH–IGF-1 axis activity

  • Support research into lipid-metabolism pathways

  • Assist investigation of adipose-tissue signalling

  • Influence body-composition markers under controlled conditions

Available evidence includes laboratory and clinical research involving regulated pharmaceutical preparations. Results from those preparations cannot be assumed to apply to an independently supplied research compound.

Premium Research Compound. One Easy Order.

OZZ Peptides Tesamorelin 10 mg provides researchers with a convenient option for investigating GHRH-receptor activity, pituitary signalling, GH–IGF-1 pathways, lipid metabolism, and adipose-tissue biology.

Securely packed and shipped directly from the Gold Coast using Australia Post Express Post.

Product Highlights

🧬 GHRH-Analogue Research
A stabilised 44-amino-acid analogue of human growth-hormone-releasing hormone.

🔬 Pituitary-Signalling Research
Investigated for its interaction with GHRH receptors on pituitary somatotroph cells.

📈 GH–IGF-1 Axis Research
Studied in relation to endogenous growth-hormone secretion and IGF-1-associated signalling.

🧫 Adipose-Tissue Research
Used in controlled studies examining visceral-adipose-tissue and body-composition pathways.

Lipid-Metabolism Research
Investigated in relation to lipolysis, triglyceride metabolism, and cellular-energy regulation.

🔄 Endocrine-Pathway Research
Studied for its role in receptor-mediated and pulsatile endocrine signalling.

💎 Over 99% Purity
Premium-quality research compound.

📦 Fast Australian Delivery
Sent using Australia Post Express Post.

🌴 Gold Coast Based
Packed and shipped by the OZZ Peptides team in Queensland.

What You’ll Receive

  • 1x Tesamorelin 10 mg vial

  • Securely packed for delivery

  • Australia Post Express Post

Storage

Store according to the storage information supplied with the product.

Before reconstitution, keep the vial in a cool, dry environment away from direct sunlight. After reconstitution, appropriate refrigerated storage may be required according to the supplier’s specifications and applicable laboratory protocol.

Important Information

Products supplied by OZZ Peptides are intended for laboratory research purposes only and are not intended for human consumption, injection, growth-hormone enhancement, fat loss, weight management, body-composition modification, performance enhancement, diagnosis, treatment, cure, or prevention of any disease.

This Tesamorelin research preparation has not been evaluated by the Australian Therapeutic Goods Administration for safety, quality, or effectiveness and is not supplied as an approved medicine.

Athlete warning: Growth-hormone-releasing factors and their analogues are prohibited under the World Anti-Doping Agency Prohibited List. Competitive athletes should not use or handle this product outside properly authorised research settings.

OZZPEPTIDES.COM

A premium research compound supplied in a convenient 10 mg vial.

Tesamorelin is a stabilised synthetic analogue of human growth-hormone-releasing hormone. It is investigated in laboratory and clinical research involving GHRH-receptor activity, pituitary signalling, growth-hormone secretion, the GH–IGF-1 axis, lipid metabolism, and body-composition pathways.

What’s Included

  • 1x Tesamorelin 10 mg vial

  • Over 99% Purity

  • Premium-quality research compound

  • Shipped from the Gold Coast, Queensland

  • Australia Post Express Post

Why Choose Tesamorelin 10 mg?

Tesamorelin is a modified 44-amino-acid analogue corresponding to the full sequence of human growth-hormone-releasing hormone.

Researchers investigate Tesamorelin in relation to:

  • GHRH-receptor activation

  • Pituitary somatotroph-cell activity

  • Growth-hormone secretion pathways

  • GH–IGF-1 axis signalling

  • Pulsatile endocrine activity

  • Lipid-metabolism pathways

  • Adipose-tissue signalling

  • Body-composition research

Its stabilised GHRH-based structure makes Tesamorelin an important compound for specialised endocrine, pituitary, metabolic, and receptor-signalling research.

Tesamorelin Research

Tesamorelin is commonly investigated in laboratory and clinical research relating to:

  • Growth-hormone-releasing hormone activity

  • GHRH-receptor binding and activation

  • Pituitary-cell signalling

  • Growth-hormone secretory responses

  • IGF-1-associated pathways

  • Somatotropic-axis activity

  • Visceral-adipose-tissue metabolism

  • Lipolytic signalling

  • Triglyceride-metabolism pathways

  • Glucose-regulation mechanisms

  • Liver-fat research

  • Body-composition changes

Research continues into how Tesamorelin influences pituitary signalling, endogenous growth-hormone release, IGF-1-associated activity, lipid metabolism, and adipose-tissue pathways.

Growth-Hormone-Releasing Hormone Analogue Research

Tesamorelin is a synthetic analogue of human GHRH (1–44) with an N-terminal modification designed to improve resistance to enzymatic degradation.

It is composed of the following 44-amino-acid sequence:

Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Researchers investigate this specialised peptide for its potential to:

  • Bind to growth-hormone-releasing hormone receptors

  • Activate receptor-mediated pituitary signalling

  • Influence endogenous growth-hormone secretion

  • Affect GH–IGF-1 axis activity

  • Support research into lipid-metabolism pathways

  • Assist investigation of adipose-tissue signalling

  • Influence body-composition markers under controlled conditions

Available evidence includes laboratory and clinical research involving regulated pharmaceutical preparations. Results from those preparations cannot be assumed to apply to an independently supplied research compound.

Premium Research Compound. One Easy Order.

OZZ Peptides Tesamorelin 10 mg provides researchers with a convenient option for investigating GHRH-receptor activity, pituitary signalling, GH–IGF-1 pathways, lipid metabolism, and adipose-tissue biology.

Securely packed and shipped directly from the Gold Coast using Australia Post Express Post.

Product Highlights

🧬 GHRH-Analogue Research
A stabilised 44-amino-acid analogue of human growth-hormone-releasing hormone.

🔬 Pituitary-Signalling Research
Investigated for its interaction with GHRH receptors on pituitary somatotroph cells.

📈 GH–IGF-1 Axis Research
Studied in relation to endogenous growth-hormone secretion and IGF-1-associated signalling.

🧫 Adipose-Tissue Research
Used in controlled studies examining visceral-adipose-tissue and body-composition pathways.

Lipid-Metabolism Research
Investigated in relation to lipolysis, triglyceride metabolism, and cellular-energy regulation.

🔄 Endocrine-Pathway Research
Studied for its role in receptor-mediated and pulsatile endocrine signalling.

💎 Over 99% Purity
Premium-quality research compound.

📦 Fast Australian Delivery
Sent using Australia Post Express Post.

🌴 Gold Coast Based
Packed and shipped by the OZZ Peptides team in Queensland.

What You’ll Receive

  • 1x Tesamorelin 10 mg vial

  • Securely packed for delivery

  • Australia Post Express Post

Storage

Store according to the storage information supplied with the product.

Before reconstitution, keep the vial in a cool, dry environment away from direct sunlight. After reconstitution, appropriate refrigerated storage may be required according to the supplier’s specifications and applicable laboratory protocol.

Important Information

Products supplied by OZZ Peptides are intended for laboratory research purposes only and are not intended for human consumption, injection, growth-hormone enhancement, fat loss, weight management, body-composition modification, performance enhancement, diagnosis, treatment, cure, or prevention of any disease.

This Tesamorelin research preparation has not been evaluated by the Australian Therapeutic Goods Administration for safety, quality, or effectiveness and is not supplied as an approved medicine.

Athlete warning: Growth-hormone-releasing factors and their analogues are prohibited under the World Anti-Doping Agency Prohibited List. Competitive athletes should not use or handle this product outside properly authorised research settings.

OZZPEPTIDES.COM